First-in-Human trial tests new shot for genetic lung and liver disease
Disease control
Recruiting now
This is a first-step study to see if a new injected medicine called AIR-001 is safe and how it behaves in the body of people with Alpha-1 Antitrypsin Deficiency (AATD). It will enroll 54 adults with a specific genetic form (PiZZ) of the disease. The main goal is to check for side…
Phase: PHASE1 • Sponsor: AIRNA Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC